You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 14, 2025

Drug Price Trends for MICONAZOLE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for MICONAZOLE

Average Pharmacy Cost for MICONAZOLE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
MICONAZOLE 2% TOPICAL CREAM 61269-0735-14 0.11219 GM 2024-12-18
MICONAZOLE-7 CREAM 70000-0009-01 0.13494 GM 2024-12-18
MICONAZOLE 2% TOPICAL CREAM 51672-2001-01 0.20090 GM 2024-12-18
MICONAZOLE 2% TOPICAL CREAM 00536-1134-28 0.13296 GM 2024-12-18
MICONAZOLE 2% TOPICAL CREAM 00536-1375-75 0.13296 GM 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for MICONAZOLE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
MICONAZOLE 7 United Drug Supply, Inc. 00113-0214-29 45GM 4.12 0.09156 GM 2023-12-01 - 2028-11-30 FSS
MICONAZOLE 7 United Drug Supply, Inc. 00113-0825-29 45GM 4.12 0.09156 GM 2023-12-01 - 2028-11-30 FSS
MICONAZOLE-3 United Drug Supply, Inc. 00113-0081-00 1 5.87 5.87000 EACH 2023-12-01 - 2028-11-30 FSS
AZOLEN 2% TINCTURE,TOP Stratus Pharmaceuticals, Inc. 58980-0818-10 29.57ML 10.35 0.35002 ML 2023-10-01 - 2028-09-30 FSS
AZOLEN 2% SOLN,TOP Stratus Pharmaceuticals, Inc. 58980-0819-60 170ML 12.95 0.07618 ML 2024-01-01 - 2028-09-30 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Miconazole

Introduction to Miconazole

Miconazole, an antifungal medication, is widely used to treat various fungal infections. It is available in several forms, including creams, ointments, powders, and vaginal suppositories. Here’s a comprehensive analysis of the miconazole market, including its current state, growth projections, and pricing trends.

Global Market Size and Growth

The global miconazole market has been experiencing significant growth. As of 2023, the market size was valued at several million dollars, with a projected compound annual growth rate (CAGR) that indicates robust expansion from 2024 to 2031[1][2].

  • Market Size: The global miconazole market size in 2023 was substantial, and it is expected to grow steadily over the next few years.
  • CAGR: The market is anticipated to exhibit a notable CAGR from 2024 to 2031, reflecting strong growth dynamics[1][2].

Regional Analysis

The miconazole market is segmented into several key regions, each contributing significantly to the global market share.

  • North America: This region has historically dominated the market share due to high demand and advanced healthcare infrastructure[3].
  • Europe: Europe is another significant market, driven by increasing cases of fungal infections and a well-developed pharmaceutical sector.
  • Asia Pacific: This region is expected to show rapid growth due to increasing healthcare spending and a large population base[1][2].
  • Latin America and Middle East & Africa: These regions are also growing, driven by improving healthcare access and rising awareness about antifungal treatments[1].

Market Segmentation

The miconazole market is segmented based on type, application, and end-use.

  • Type: The market includes various types of miconazole formulations such as creams, ointments, powders, and vaginal suppositories. The azoles segment, which includes miconazole, is expected to be a leading segment in the antifungal drugs market[3].
  • Application: Key applications include medical treatment and prophylactic use. Miconazole is widely used for treating vaginal yeast infections, skin infections, and other fungal infections[4].
  • End-Use: The end-users include hospitals, clinics, and retail pharmacies. The demand from these sectors is driven by the increasing prevalence of fungal infections[2].

Market Drivers and Restraints

Several factors drive and restrain the growth of the miconazole market.

  • Drivers: Increase in the prevalence of fungal infections, new product launches, and growing pipeline analysis by market players are key drivers. Additionally, expanding brand awareness through targeted marketing campaigns and increasing demand in emerging markets contribute to market growth[2][4].
  • Restraints: Market restraints include consumer awareness barriers, especially in rural and underserved regions, and the presence of alternative treatment preferences. Regulatory challenges and market penetration obstacles also impact the market[4].

Price Trends and Projections

The pricing of miconazole products varies based on the formulation and quantity.

  • Current Prices: A 14-gram supply of 2% miconazole topical cream can cost around $10.21, with prices varying slightly based on the quantity. Topical liquids and other formulations also have varying price points[5].
  • Price Projections: The prices are expected to remain competitive due to the presence of multiple vendors and generic options. However, advancements in formulations and targeted marketing could slightly increase prices in the future[5].

Competitive Landscape

The miconazole market is highly competitive with several key players.

  • Leading Players: Companies like Astellas Pharma are prominent in the global antifungal drugs market, including miconazole. Other players include United Drug Supply, Inc., Stratus Pharmaceuticals, Inc., and AvKare, LLC[3][5].
  • Market Share Analysis: The market share analysis reveals a competitive landscape where vendors compete based on revenue, customer base, and product range. Strategic approaches, product innovations, and regulatory approvals are crucial for gaining a competitive edge[4].

PESTLE Analysis

Understanding the external macro-environmental factors is crucial for navigating the miconazole market.

  • Political Factors: Regulatory changes and healthcare policies significantly impact the market.
  • Economic Factors: National GDP, market dynamics, and consumer spending power influence the demand for miconazole.
  • Social Factors: Consumer behavior, awareness about health, and social media influence market trends.
  • Technological Factors: Advancements in formulations, manufacturing capabilities, and research and development efforts drive market growth.
  • Legal Factors: Compliance with regulatory standards and patent analysis are essential.
  • Environmental Factors: Environmental considerations and sustainability initiatives can impact the market[4].

Consumer Behavior and Market Penetration

Consumer behavior plays a critical role in the adoption of miconazole products.

  • Consumer Awareness: Increasing awareness about fungal infections and the importance of antifungal treatments drives demand.
  • Market Penetration: Effective marketing strategies and expanding brand awareness are key to penetrating both urban and rural markets[4].

Key Takeaways

  • The global miconazole market is expected to grow significantly from 2024 to 2031.
  • Regional analysis highlights North America and Europe as dominant markets, with Asia Pacific showing rapid growth.
  • Market segmentation reveals azoles as a leading segment, with medical treatment and prophylactic use as key applications.
  • Drivers include increasing prevalence of fungal infections and new product launches, while restraints include consumer awareness barriers and regulatory challenges.
  • Pricing trends indicate competitive pricing with potential slight increases due to advancements in formulations.

FAQs

1. What is the current market size of the global miconazole market? The current market size of the global miconazole market was valued at several million dollars in 2023.

2. What is the projected CAGR for the miconazole market from 2024 to 2031? The miconazole market is anticipated to exhibit a notable CAGR from 2024 to 2031, indicating robust growth.

3. Which regions are dominant in the miconazole market? North America and Europe are currently the dominant regions, with Asia Pacific expected to show rapid growth.

4. What are the key drivers of the miconazole market? Key drivers include the increasing prevalence of fungal infections, new product launches, and growing pipeline analysis by market players.

5. How do pricing trends look for miconazole products? Pricing trends indicate competitive pricing, with potential slight increases due to advancements in formulations and targeted marketing.

Cited Sources

  1. Cognitive Market Research: "Global Miconazole market size 2023 was XX Million. Miconazole Industry compound annual growth rate (CAGR) will be XX% from 2024 till 2031."
  2. Market Research Intellect: "Miconazole Nitrate Market reached a value of USD xx billion in 2023 and is anticipated to attain USD xx billion by the conclusion of 2031..."
  3. Fortune Business Insights: "The global antifungal drugs market size was valued at USD 10.24 billion in 2019 and is projected to reach USD 13.17 billion by 2027..."
  4. 360iResearch: "Miconazole Nitrate Vaginal Soft Capsules Market by Component (Active Ingredient, Excipients), Application (Medical Treatment, Prophylactic Use)..."
  5. Drug Patent Watch: "A 14-gram supply of 2% miconazole topical cream can cost around $10.21, with prices varying slightly based on the quantity..."

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.